Author:
Boukovala Myrto,Spetsieris Nicholas,Efstathiou Eleni
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Geriatrics and Gerontology
Reference137 articles.
1. National Cancer Institute. Surveillance, Epidemiology, and End Results Program (SEER). Cancer stat facts: prostate cancer. [cited 11/20/2018].
2. World Health Organization. International Agency for Research on Cancer—GLOBOCAN 2018. [cited 11/20/2018].
3. United States Census Bureau. Projections of the populations of the United States: 1982 to 2050 (advance report). 1982 [cited 11/20/2018].
4. Graff JN, Baciarello G, Armstrong AJ, Higano CS, Iversen P, Flaig TW, et al. Efficacy and safety of enzalutamide in patients 75 years or older with chemotherapy-naive metastatic castration-resistant prostate cancer: results from PREVAIL. Ann Oncol. 2016;27(2):286–94.
5. Kongsted P, Svane IM, Lindberg H, Sengelov L. Predictors of chemotherapy-induced toxicity and treatment outcomes in elderly versus younger patients with metastatic castration-resistant prostate cancer. Clin Genitourin Cancer. 2016;14(6):e559–68.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献